Abstract
The popularity of St. John’s Wort (SJW) extracts for treating mild to moderate depression has increased over the last decades and great effort has been devoted to identify the active principle of SJW extract. Previous investigations suggest the contribution of at least three classes of compounds, the phloroglucinols, the quercetin flavonoids, and the phenanthroperylenequinones, to the clinical efficiency of SJW extracts. Up to now, a plausible molecular mechanism of action has been described only for the phloroglucinols. For the flavonoids and the phenanthroperylenequinones different targets were proposed on the basis of pharmacological studies. The vast majority of these targets are located in the CNS and therefore increasing interest in the question of the CNS availability of these substances arose. Recently, the ability of phloroglucinols and flavonoids to penetrate the blood brain barrier could be demonstrated. For the phenanthroperylenequinones an examination of CNS bioavailability is still missing.
The aim of this work is to close this gap by developing and validating a HPLC method with electrochemical detection for the quantification of the phenanthroperylenequinones in brain tissue of rodents after oral application of SJW extract or pure hypericin. In our study, the phenanthroperylenequinone content in the CNS tissue was below the lower limit of detection of the analytical method and was thus lower than 16 pmol/g brain for hypericin and lower than 52 pmol/g brain for pseudohypericin after oral administration of 1600 mg/kg SJW extract or pure hypericin (5 mg/kg).
Similar content being viewed by others
References
E Richelson (1993) Psychiatry Clin North Am 16 461 Occurrence Handle1:STN:280:DyaK2c%2FitFKmtQ%3D%3D
JP Lepine M Gastpar J Mendlewicz A Tylee (1997) Int Clin Psychopharmacol 12 19 Occurrence Handle10.1097/00004850-199705002-00005 Occurrence Handle1:STN:280:DyaK2szitlWnsg%3D%3D
Linde K, Mulrow C, Berner M, Egger M (2005) Cochrane Database Syst Rev:CD000448
K Linde L Knuppel (2005) Phytomedicine 12 148 Occurrence Handle10.1016/j.phymed.2004.02.004 Occurrence Handle1:STN:280:DC%2BD2M%2FmsFWhsA%3D%3D
WE Müller (2003) Pharmacol Res 47 101 Occurrence Handle10.1016/S1043-6618(02)00266-9
JH Keller M Karas WE Müller DA Volmer GP Eckert MA Tawab HH Blume T Dingermann M Schubert-Zsilavecz (2003) Anal Chem 75 6084 Occurrence Handle10.1021/ac034520z Occurrence Handle1:CAS:528:DC%2BD3sXnvV2qtb0%3D
S Schulte-Löbbert G Holoubek WE Muller M Schubert-Zsilavecz M Wurglics (2004) J Pharm Pharmacol 56 813 Occurrence Handle10.1211/0022357023493 Occurrence Handle1:CAS:528:DC%2BD2cXmtFSksLY%3D
A Singer M Wonnemann WE Müller (1999) J Pharmacol Exp Ther 290 1363 Occurrence Handle1:CAS:528:DyaK1MXlsVOqtL8%3D
N Roz M Rehavi (2003) Life Sci 73 461 Occurrence Handle10.1016/S0024-3205(03)00295-9 Occurrence Handle1:CAS:528:DC%2BD3sXjvFant7o%3D
WE Müller M Rolli C Schäfer U Hafner (1997) Pharmacopsychiatry 30 IssueIDSuppl 2 102 Occurrence Handle10.1055/s-2007-979528
A Paulke M Schubert-Zsilavecz M Wurglics (2006) J Chromatogr B Analyt Technol Biomed Life Sci 832 109 Occurrence Handle10.1016/j.jchromb.2005.12.043 Occurrence Handle1:CAS:528:DC%2BD28Xhtlarsbs%3D
Paulke A, Nöldner M, Schubert-Zsilavecz M, Wurglics M (2007) submitted
A Singh PS Naidu SK Kulkarni (2003) Pharmacology 68 81 Occurrence Handle10.1159/000069533 Occurrence Handle1:CAS:528:DC%2BD3sXksVKrtLo%3D
HM Thiede A Walper (1994) J Geriatr Psychiatry Neurol 7 IssueIDSuppl 1 S54 Occurrence Handle10.1177/089198879400700114
V Butterweck B Korte H Winterhoff (2001) Pharmacopsychiatry 34 IssueIDSuppl 1 S2 Occurrence Handle10.1055/s-2001-15508 Occurrence Handle1:CAS:528:DC%2BD3MXmt1ansL8%3D
V Butterweck M Hegger H Winterhoff (2004) Planta Med 70 1008 Occurrence Handle10.1055/s-2004-832631 Occurrence Handle1:CAS:528:DC%2BD2cXpsVWls7s%3D
RD Porsolt (1979) Biomedicine 30 139 Occurrence Handle1:STN:280:DyaL3c%2FitFCnsA%3D%3D
M Nöldner (2001) Antidepressive Effekte von Johanniskrautextrakt und wichtigen Inhaltsstoffen im Tiermodell WE Müller M Gastpar (Eds) Behandlung von depressiven Patienten in der täglichen Praxis NumberInSeries1 LinguaMed Verlags-GmbH Neu-Isenburg 31
M Nöldner K Schötz (2002) Planta Med 68 577 Occurrence Handle10.1055/s-2002-32908
O Suzuki Y Katsumata M Oya S Bladt H Wagner (1984) Planta Med 50 272 Occurrence Handle10.1055/s-2007-969700 Occurrence Handle1:CAS:528:DyaL2MXhslyqtbw%3D
L Demisch J Hölzl B Gollnik P Kaczmarczyk (1989) Pharmacopsychiatry 22 194
V Butterweck A Nahrstedt J Evans S Hufeisen L Rauser J Savage B Popadak P Ernsberger BL Roth (2002) Psychopharmacology (Berl) 162 193 Occurrence Handle10.1007/s00213-002-1073-7 Occurrence Handle1:CAS:528:DC%2BD38Xmtlertbs%3D
V Butterweck T Bockers B Korte W Wittkowski H Winterhoff (2002) Brain Res 930 21 Occurrence Handle10.1016/S0006-8993(01)03394-7 Occurrence Handle1:CAS:528:DC%2BD38XhslWju7k%3D
E Fox RF Murphy CL McCully PC Adamson (2001) Cancer Chemother Pharmacol 47 41 Occurrence Handle10.1007/s002800000188 Occurrence Handle1:CAS:528:DC%2BD3MXlsVWntQ%3D%3D
CM Pariante (2003) J Neuroendocrinol 15 811 Occurrence Handle10.1046/j.1365-2826.2003.01058.x
S Bauer E Stormer HJ Graubaum I Roots (2001) J Chromatogr B Biomed Sci Appl 765 29 Occurrence Handle10.1016/S0378-4347(01)00390-5 Occurrence Handle1:CAS:528:DC%2BD3MXot1Ohtrg%3D
V Butterweck U Lieflander-Wulf H Winterhoff A Nahrstedt (2003) Planta Med 69 189 Occurrence Handle10.1055/s-2003-38495 Occurrence Handle1:CAS:528:DC%2BD3sXjt1Srs7s%3D
JD Chi M Franklin (1999) J Chromatogr B Biomed Sci Appl 724 195 Occurrence Handle10.1016/S0378-4347(98)00572-6 Occurrence Handle1:CAS:528:DyaK1MXhvF2ru70%3D
EM Gioti DC Skalkos YC Fiamegos CD Stalikas (2005) J Chromatogr A 1093 1 Occurrence Handle10.1016/j.chroma.2005.07.038 Occurrence Handle1:CAS:528:DC%2BD2MXhtFeiurfE
R Kerb J Brockmöller B Staffeldt M Ploch I Roots (1996) Antimicrob Agents Chemother 40 2087 Occurrence Handle1:CAS:528:DyaK28XlsVChtr8%3D
R Pirker CW Huck GK Bonn (2002) J Chromatogr B Analyt Technol Biomed Life Sci 777 147 Occurrence Handle10.1016/S1570-0232(02)00080-6 Occurrence Handle1:CAS:528:DC%2BD38Xos1Wrtbw%3D
KD Riedel K Rieger M Martin-Facklam G Mikus WE Haefeli J Burhenne (2004) J Chromatogr B Analyt Technol Biomed Life Sci 813 27 Occurrence Handle10.1016/j.jchromb.2004.09.061 Occurrence Handle1:CAS:528:DC%2BD2cXhtVSns7vO
K Westerhoff (2002) Vergleichende Untersuchungen zur Pharmazeutischen Qualität von Phytopharmaka am Beispiel von Johanniskrautextrakt-Präparaten Johann-Wolfgang-Goethe Universität Frankfurt
M Wurglics M Schubert-Zsilavecz (2006) Clin Pharmacokinet 45 449 Occurrence Handle10.2165/00003088-200645050-00002 Occurrence Handle1:CAS:528:DC%2BD28Xlt1Kgsb4%3D
AH Schmidt (2003) J Chromatogr A 987 181 Occurrence Handle10.1016/S0021-9673(02)01808-3 Occurrence Handle1:CAS:528:DC%2BD3sXptl2isA%3D%3D
Author information
Authors and Affiliations
Corresponding author
Additional information
Correspondence: Mario Wurglics, Institute of Pharmaceutical Chemistry, Johann Wolfgang Goethe University/ZAFES, 60438 Frankfurt am Main, Germany.
Rights and permissions
About this article
Cite this article
Paulke, A., Schubert-Zsilavecz, M. & Wurglics, M. Determination of hypericin and pseudohypericin from Hypericum perforatum in rat brain after oral administration. Monatsh Chem 139, 489–494 (2008). https://doi.org/10.1007/s00706-007-0792-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-007-0792-1